Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Enanta Pharmaceuticals, Inc

Clinical trials sponsored by Enanta Pharmaceuticals, Inc, explained in plain language.

Enanta Pharmaceuticals, Inc. ENTA NASDAQ

Biotech focused on antiviral and respiratory disease treatments.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Completed 1

New RSV pill shows promise in early human trial

Disease control Completed

This study tested an experimental oral drug called EDP-323 in 142 healthy adults who were deliberately infected with RSV. The goal was to see if the drug is safe and can reduce the amount of virus in the nose compared to a placebo. Results will help determine if EDP-323 could be …

Phase: PHASE2 • Sponsor: Enanta Pharmaceuticals, Inc • Aim: Disease control

Last updated Jun 27, 2026 07:53 UTC